December 16, 2020 10:54 AM EST
News Briefing

News brief­ing: Bob Cough­lin is jump­ing in­to re­al es­tate — in a big way; Keytru­da plus Lenvi­ma posts pos­i­tive PhI­II da­ta in en­dome­tri­al can­cer

John Carroll

Editor & Founder

We know now where Mass­Bio chief Bob Cough­lin is head­ed. JLL re­ports that Cough­lin is join­ing the bro­kers hatch­ing new …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
ENDPOINTS CAREERS

Director Oligonucleotide R&D

Bachem

Bubendorf, BL, Switzerland

TRENDING NOW

Pfiz­er wants in on Sum­mit’s goal to beat Keytru­da via ADC com­bos

Post-Hoc: Phar­ma CEOs' al­ter­na­tive re­al­i­ty with Trump

Sanofi, Te­va bol­ster case for IBD drug with Phase 2 da­ta, de­spite po­ten­tial com­pe­ti­tion

CBER's deputy di­rec­tor de­parts as staff shake­up con­tin­ues

FDA ap­proves first drug to treat ul­tra-rare lipid stor­age dis­ease

sponsored

How AI can ad­dress on­go­ing chal­lenges in the life sci­ences in­dus­try

A service from the Financial Times